Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07284498 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Treatment of Seizures in Neonate With HIE

Study acronym: HIE
StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 16, 2025 (before its estimated September 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Mansoura University
270 trials monitored
See 3 trials at risk
Epilepsy
730 trials monitored
See 45 trials at risk
Aim of the study To evaluate and compare phenobarbital's and levetiracetam's safety and efficacy for treating seizures in neonates with moderate to severe HIE
Trial Details
NCT Number NCT07284498
Lead Sponsor Mansoura University
Conditions Neonatal Seizures, HIE - Hypoxic - Ischemic Encephalopathy
Enrollment 66 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov